
Dapaglor 10mg Tablet
Marketer
Biostella Pharma (opc) Private Limited
Salt Composition
Dapagliflozin (10mg)
Overview Dapaglor 10mg Tablet
Empagliflozin 10mg tablets are prescribed, either independently or alongside other medications, for managing type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and promoting cardiovascular health. Empagliflozin 10mg tablets may be consumed with or without food, but consistent daily timing is recommended. Dosage is determined by your physician, and discontinuation requires medical consultation to avoid potential blood sugar spikes and complications such as renal impairment or vision loss. This drug is one component of a comprehensive treatment plan, incorporating dietary adjustments, physical activity, and weight management as directed by your doctor. Commonly reported side effects include vaginal yeast infections, upper respiratory infections (nasopharyngitis), and urinary tract infections. Fluid loss is possible; adequate hydration is crucial to prevent dehydration. Good hygiene practices can reduce the likelihood of genital fungal infections. Prior to commencing treatment, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before starting this medication. Limit alcohol consumption, as excessive intake may heighten the risk of adverse effects. Regular blood glucose monitoring is essential during treatment.
Uses of Dapaglor 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapaglor 10mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaglor 10mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Dapaglor 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaglor 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Dapaglor 10mg Tablets can be administered with or without food, although consistent timing is recommended.
How Dapaglor 10mg Tablet works:
Glyxambi 10mg tablets are prescribed for diabetes management. Their action involves eliminating surplus glucose via urinary excretion.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Dapagliflozin 10mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Dapaglor 10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapagliflozin 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Dapagliflozin 10mg tablets due to potential safety concerns. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Dapaglor 10mg tablets are considered safe, and no dosage modification is necessary.
What if you forget to take Dapaglor 10mg Tablet :
Should you forget a Dapagliflozin 10mg Tablet dose, take it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaglor 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
| Active Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
